Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
This is an open-label study to provide continued access to treatment for eligible participants who continue to derive clinical benefit as determined by the investigator from study intervention(s) in a Pfizer-sponsored palbociclib clinical study (Parent Study)
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Any participant who is receiving study treatment and deriving clinical benefit as determined by the investigator in a Pfizer-sponsored palbociclib Parent Study
Participants must agree to follow the reproductive criteria
Participants who are willing and able to comply with all scheduled visits, treatment plans, and other study procedures
Capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent document and protocol
You may not be if
Any medical reason that, in the opinion of the investigator or sponsor, precludes the participant from inclusion in the study
Clareo Health | Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies
